文献速递区域麻醉与超声疼痛医学

鞘内吗啡用于腹腔镜结肠节段切除术加速康复方案:一项随机对照试验

Intrathecal Morphine for Laparoscopic Segmental Colonic Resection as Part of an Enhanced Recovery Protocol: A Randomized Controlled Trial.
PubMed 文献 · Reg Anesth Pain Med · 2018-01-01

干预组达到「适合出院」时间更早(中位3天 vs 4天,P=0.044),术后第一天阿片用量更少、疼痛评分更低,除瘙痒增多外不良事件无差异。

要点

  • 鞘内布比卡因/吗啡(12.5 mg/300 μg)可缩短腹腔镜结肠节段切除术后适合出院时间
  • 干预组术后第一天阿片用量更少且疼痛评分更低
  • 除瘙痒更多外,不良事件、活动时间、液体管理和满意度无差异

核心结论

  • 在ERAS方案下,鞘内吗啡用于腹腔镜手术的术后镇痛比静脉阿片更有效,恢复更快且疼痛更轻。

研究设计与样本

  • 干预组接受单次鞘内布比卡因/吗啡(12.5 mg/300 μg),老年患者调整剂量;对照组接受假操作及哌替啶(0.1 mg/kg)静脉推注。
  • 两组均接受标准化全身麻醉、患者自控静脉镇痛泵及ERAS方案管理。

主要发现

  • 干预组达到「适合出院」时间更早(中位3天 vs 4天,P=0.044)。
  • 干预组术后第一天阿片用量显著减少,疼痛评分更低。
  • 除瘙痒更多外,不良事件、活动时间、液体管理及患者满意度无差异。

关键数值与推荐

  • 主要结局为达到「适合出院」的天数。
  • 干预组鞘内布比卡因/吗啡剂量为12.5 mg/300 μg,老年患者调整剂量。
  • 对照组哌替啶剂量为0.1 mg/kg静脉推注。

临床怎么用

  • 在ERAS方案下,可考虑对腹腔镜结肠节段切除术患者使用鞘内布比卡因/吗啡以加速康复并减少阿片用量。
  • 需注意干预组瘙痒发生率更高。

局限性

  • 排除脊柱麻醉禁忌、中转开腹及胃和直肠手术患者,结果外推受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Management of postoperative pain after laparoscopic segmental colonic resections remains controversial. We compared 2 methods of analgesia within an Enhanced Recovery After Surgery (ERAS) program. The goal of the study was to investigate whether administration of intrathecal bupivacaine/morphine would lead to an enhanced recovery. METHODS: A single-center, randomized, double-blind controlled trial was performed (NL43488.101.13). Patients scheduled for laparoscopic segmental intestinal resections were considered. Exclusion criteria were patients in whom contraindications to spinal anesthesia were present, conversion to open surgery, and gastric and rectal surgery. The intervention group received single-shot intrathecal bupivacaine/morphine (12.5 mg/300 μg), with an altered dose for older patients. The control group received a sham procedure and a bolus of piritramide (0.1 mg/kg). Both groups received standardized general anesthesia and a patient-controlled intravenous analgesia pump as postoperative analgesia. All patients were treated according to an ERAS protocol. A decrease in days to "fit for discharge" was the primary outcome. RESULTS: Fifty-six patients were enrolled. Intervention group patients were fit for discharge earlier (median of 3 vs 4 days, P = 0.044). Furthermore, there was a significant decrease in opioid use and lower pain scores on the first postoperative day in the intervention group. There were no differences in adverse events (except for more pruritus), time to mobilization, fluid administration, or patient satisfaction. CONCLUSIONS: This randomized controlled trial shows that intrathecal morphine is a more effective method of postoperative analgesia in laparoscopic surgery than intravenous opioids within an ERAS program. Recovery is faster and less painful with intrathecal morphine. Other studies have confirmed these results, although data on faster recovery are new and require confirmation in future trials. CLINICAL TRIAL REGISTRATION: This study was registered at ClinicalTrials.gov, identifier NCT02284282.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Koning MV, Teunissen AJW, van der Harst E, et al. Intrathecal Morphine for Laparoscopic Segmental Colonic Resection as Part of an Enhanced Recovery Protocol: A Randomized Controlled Trial. Reg Anesth Pain Med. 2018. PMID: 29219935. doi:10.1097/AAP.0000000000000703

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。